These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 11810736)
21. Length of stay and economic consequences with rivaroxaban vs enoxaparin/vitamin K antagonist in patients with DVT and PE: findings from the North American EINSTEIN clinical trial program. Bookhart BK; Haskell L; Bamber L; Wang M; Schein J; Mody SH J Med Econ; 2014 Oct; 17(10):691-5. PubMed ID: 25065536 [TBL] [Abstract][Full Text] [Related]
22. Selecting an agent for prophylaxis of venous thromboembolism. Myers J Am J Health Syst Pharm; 2006 Dec; 63(24):2448-50. PubMed ID: 17158692 [No Abstract] [Full Text] [Related]
23. Reimbursement of enoxaparin for outpatient therapy. Proceedings of regional meetings. Manag Care; 1999 Dec; 8 Suppl():7-13. PubMed ID: 11729401 [TBL] [Abstract][Full Text] [Related]
24. Prevention of venous thromboembolism after acute ischaemic stroke. Martins HS; Scalabrini-Neto A; Velasco IT Lancet; 2007 Sep; 370(9589):736; author reply 736-7. PubMed ID: 17765513 [No Abstract] [Full Text] [Related]
26. Economic analysis of low-dose heparin vs the low-molecular-weight heparin enoxaparin for prevention of venous thromboembolism after colorectal surgery. Etchells E; McLeod RS; Geerts W; Barton P; Detsky AS Arch Intern Med; 1999 Jun; 159(11):1221-8. PubMed ID: 10371230 [TBL] [Abstract][Full Text] [Related]
27. Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Alikhan R; Cohen AT; Combe S; Samama MM; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Olsson CG; Turpie AG Blood Coagul Fibrinolysis; 2003 Jun; 14(4):341-6. PubMed ID: 12945875 [TBL] [Abstract][Full Text] [Related]
28. Anticoagulation for venous thromboembolism. What are the current options? Yacovella T; Alter M Postgrad Med; 2000 Sep; 108(4):43-6, 51-4. PubMed ID: 11021258 [TBL] [Abstract][Full Text] [Related]
29. Barriers to the use of outpatient enoxaparin therapy in patients with deep venous thrombosis. Shapiro NI; Spear J; Sheehy S; Brown J; Edlow JA Am J Emerg Med; 2005 Jan; 23(1):30-4. PubMed ID: 15672334 [TBL] [Abstract][Full Text] [Related]
30. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in Medical Patients with Enoxaparin Study Group. Samama MM; Cohen AT; Darmon JY; Desjardins L; Eldor A; Janbon C; Leizorovicz A; Nguyen H; Olsson CG; Turpie AG; Weisslinger N N Engl J Med; 1999 Sep; 341(11):793-800. PubMed ID: 10477777 [TBL] [Abstract][Full Text] [Related]
31. Low-molecular-weight heparin for initial treatment of venous thromboembolism. Brewer D Am Fam Physician; 2005 Jul; 72(1):75-6. PubMed ID: 16035683 [No Abstract] [Full Text] [Related]
32. Enoxaparin for the prevention of venous thromboembolism. Axon RN; Cawley PJ Hosp Pract (1995); 2010 Feb; 38(1):112-4. PubMed ID: 20469632 [No Abstract] [Full Text] [Related]
34. Thromboprophylaxis with enoxaparin and direct oral anticoagulants in major orthopedic surgery and acutely ill medical patients: a meta-analysis. Cimminiello C; Prandoni P; Agnelli G; Di Minno G; Polo Friz H; Scaglione F; Boracchi P; Marano G; Harenberg J Intern Emerg Med; 2017 Dec; 12(8):1291-1305. PubMed ID: 28756546 [TBL] [Abstract][Full Text] [Related]
35. Management of venous thromboembolism: a systematic review for a practice guideline. Segal JB; Streiff MB; Hofmann LV; Thornton K; Bass EB Ann Intern Med; 2007 Feb; 146(3):211-22. PubMed ID: 17261856 [TBL] [Abstract][Full Text] [Related]
36. Outpatient protocols for treatment of venous thromboembolism using low-molecular-weight heparin: to treat or not to treat at home. Spyropoulos AC Arch Intern Med; 1999 May; 159(10):1139-40. PubMed ID: 10335693 [No Abstract] [Full Text] [Related]
37. Economic analyses of venous thromboembolism prevention strategies in hospitalized patients: a systematic review. Thirugnanam S; Pinto R; Cook DJ; Geerts WH; Fowler RA Crit Care; 2012 Mar; 16(2):R43. PubMed ID: 25927574 [TBL] [Abstract][Full Text] [Related]
38. The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison. Sherman DG; Albers GW; Bladin C; Fieschi C; Gabbai AA; Kase CS; O'Riordan W; Pineo GF; Lancet; 2007 Apr; 369(9570):1347-1355. PubMed ID: 17448820 [TBL] [Abstract][Full Text] [Related]
39. Cost consequence analysis of fondaparinux versus enoxaparin in the prevention of venous thromboembolism after major orthopaedic surgery in Belgium. Annemans L; Minjoulat-Rey MC; De Knock M; Vranckx K; Czarka M; Gabriel S; Haentjens P Acta Clin Belg; 2004; 59(6):346-57. PubMed ID: 15819379 [TBL] [Abstract][Full Text] [Related]
40. Ambulatory therapy of patients with free-floating proximal deep vein thrombosis is safe. Patel RK; Ramasamy K; Goss D; Deane C; Bonner L; Arya R Thromb Haemost; 2005 Dec; 94(6):1343-4. PubMed ID: 16411421 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]